Is category 'A' status assigned to soy protein and coronary heart disease risk reduction health claim by the United States food and drug administration still justifiable?

Trends in Food Science and Technology

Volumn 30, Issue 2, 2013, Pages 121-132

  Girgih, A T ^a   Myrie, S B ^a   Aluko, R E ^a   Jones, P J H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY HEART DISEASE; HEALTH CLAIMS; HEART DISEASE; LIPID-LOWERING EFFECTS; RANKING SYSTEM; SCIENTIFIC DATA; SOY PROTEIN; UNITED STATES FOOD AND DRUG ADMINISTRATIONS;

CARDIOLOGY; DISEASES; FOOD SUPPLY; HEALTH; POWER QUALITY; PROTEINS;

HEALTH RISKS;

GLYCINE MAX;

EID: 84876159090     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2012.12.003     Document Type: Review

References (72)

1. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation 1990, 201(Suppl.):3-23.
2. Anderson J.W., Bush H.M. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. Journal of the American College of Nutrition 2011, 30:79-91.
3. Anderson J.W., Johnstone B.M., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 1995, 333:276-282.
4. Anthony M.S. Soy and cardiovascular disease: cholesterol lowering and beyond. Journal of Nutrition 2000, 130:662S-663S.
5. Atteritano M., Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2007, 92:3068-3075.
6. Bakhit R.M., Klein B.P., Essex-Sorlie D., Ham J.O., Erdman J.W., Potter S.M. Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. Journal of Nutrition 1994, 124:213-222.
7. Balk, E., Chung, M., Chew, P., Ip, S., Raman, G., Kupelnick, B., et al. Effects of Soy on Health Outcomes. Summary, Evidence Report/Technology Assessment: Number 126. AHRQ Publication Number 05-E024-1, August 2005. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/soysum.htm.
8. Baum J.A., Teng H., Erdman J.W., Weigel R.M., Klein B.P., Persky V.W., et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American Journal of Clinical Nutrition 1998, 68:545-551.
9. Bricarello L.P., Kasinski N., Bertolami M.C., Faludi A., Pinto L.A., Relvas W.G.M., et al. Comparison between the effects of soy milk and non-fat cow milk on lipid profile and lipid peroxidation in patients with primary hypercholesterolemia. Nutrition 2004, 20:200-204.
10. Campbell S.C., Khalil D.A., Payton M.E., Arjmandi B.H. One-year soy protein supplementation does not improve lipid profile in postmenopausal women. Menopause 2010, 17:587-593.
11. Carroll K.K., Giovannetti P.M., Huff M.W., Moase O., Roberts D.C., Wolfe B.M. Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet of healthy young women. American Journal of Clinical Nutrition 1978, 31:1312-1321.
12. Chan Y.-H., Lau K.-K., Yiu K.-H., Li S.-W., Chan H.-T., Tam S., et al. Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden. American Journal of Clinical Nutrition 2007, 86:938-945.
13. Clerici C., Setchell K.D., Battezzati P.M., Pirro M., Giuliano V., Asciutti S., et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. Journal of Nutrition 2007, 137:2270-2278.
14. Crouse J.R., Morgan T., Terry J.G., Ellis J., Vitolins M., Burke G.L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives of Internal Medicine 1999, 159:2070-2076.
15. Dalais F.S., Ebeling P.R., Kotsopoulos D., McGrath B.P., Teede H.J. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clinical Endocrinology (Oxford) 2003, 58:704-709.
16. Demonty I., Lamarche B., Jones P.J. Role of isoflavones in the hypocholesterolemic effect of soy. Nutrition Reviews 2003, 61:189-203.
17. Dewell A., Hollenbeck P.L., Hollenbeck C.B. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. Journal of Clinical Endocrinology and Metabolism 2006, 91:772-780.
18. EFSA - European Food Safety Authority Scientific opinion on the substantiation of a health claim related to soy protein and reduction of blood cholesterol concentrations pursuant to article 14 of the Regulation (EC) No 1924/2006. EFSA Journal 2010, 8(7):1688.
19. EFSA - European Food Safety Authority Scientific opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2012, 10(2):2555.
20. EFSA - European Food Safety Authority Response to comments on the scientific opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to article 14 of Regulation (EC) No 1924/2006 Supporting publications 2012:305. (7 pp.). Available online. http://www.efsa.europa.eu.
21. Ellwood K.C., Trumbo P.R., Kavanaugh C.J. How the US Food and Drug Administration evaluates the scientific evidence for health claims. Nutrition Reviews 2010, 68:114-121.
22. Engelman H.M., Alekel D.L., Hanson L.N., Kanthasamy A.G., Reddy M.B. Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women. American Journal of Clinical Nutrition 2005, 81:590-596.
23. Erdman J.W. AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000, 102:2555-2559.
24. FDA Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Federal Register 1999, 64:57700-57733.
25. FDA Types of claims: Definitions, guidance, regulatory information, and permitted claims 2012, US Food and Drug Administration, Available at, Accessed 05.08.12. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/default.htm.
26. FDA Consumer health information for better nutrition initiative: Task force final report 2012, US Food and Drug Administration, Available at, Accessed 05.08.12. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/QualifiedHealthClaimsPetitions/ucm096010.htm.
27. FDA Guidance for industry: Evidence-based review system for the scientific evaluation of health claims - Final 2012, US Food and Drug Administration, Available at, Accessed 05.08.12. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/ucm073332.htm.
28. Fitzpatrick L.A. Soy isoflavones: hope or hype?. Maturitas 2003, 44(Suppl. 1):S21-S29.
29. Food Labeling Health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule. Federal Register 2008, 73:47828-47829.
30. Food Labeling Health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule. Federal Register 2008, 73:23947-23953.
31. Gaddi A., Ciarrocchi A., Matteucci A., Rimondi S., Ravaglia G., Descovich G.C., et al. Dietary treatment for familial hypercholesterolemia - differential effects of dietary soy protein according to the apolipoprotein E phenotypes. American Journal of Clinical Nutrition 1991, 53:1191-1196.
32. Gardner C.D., Newell K.A., Cherin R., Haskell W.L. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. American Journal of Clinical Nutrition 2001, 73:728-735.
33. Giovannetti P.M., Carroll K.K., Wolfe B.M. Constancy of fasting serum cholesterol of healthy young women upon substitution of soy protein isolate for meat and dairy protein in medium and low fat diets. Nutrition Research 1986, 6:609-618.
34. Goldberg A.P., Lim A., Kolar J.B., Grundhauser J.J., Steinke F.H., Schonfeld G. Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia. Atherosclerosis 1982, 43:355-368.
35. Hasler C.M. Health claims in the United States: an aid to the public or a source of confusion?. Journal of Nutrition 2008, 138:1216S-1220S.
36. Hodgson J.M., Puddey I.B., Beilin L.J., Mori T.A., Croft K.D. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. Journal of Nutrition 1998, 128:728-732.
37. Holmes W.L., Rubel G.B., Hood S.S. Comparison of the effect of dietary meat versus dietary soybean protein on plasma lipids of hyperlipidemic individuals. Atherosclerosis 1980, 36:379-387.
38. Jenkins D.J., Mirrahimi A., Srichaikul K., Berryman C.E., Wang L., Carleton A., et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. Journal of Nutrition 2010, 140:2302S-2311S.
39. Kurowska E.M., Jordan J., Spence J.D., Wetmore S., Piche L.A., Radzikowski M., et al. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clinical and Investigative Medicine 1997, 20:162-170.
40. Lichtenstein A.H., Jalbert S.M., Adlercreutz H., Adlercreutz H., Goldin B.R., Rasmussen H., et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:1852-1858.
41. Lovati M.R., Manzoni C., Canavesi A., Sirtori M., Vaccarino V., Marchi M., et al. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. Journal of Clinical Investigation 1987, 80:1498-1502.
42. Matthan N.R., Jalbert S.M., Ausman L.M., Kuvin J.T., Karas R.H., Lichtenstein A.H. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. American Journal of Clinical Nutrition 2007, 85:960-966.
43. Meinertz H., Nilausen K., Faergeman O. Soy protein and casein in cholesterol-enriched diets: effects on plasma lipoproteins in normolipidemic subjects. American Journal of Clinical Nutrition 1989, 50:786-793.
44. Mercer N.J.H., Carroll K.K., Giovannetti P.M. Effects on human plasma lipids of substituting soybean protein isolate for milk protein in the diet. Nutrition Reports International 1987, 35:279-287.
45. Nagarajan S. Mechanisms of anti-atherosclerotic functions of soy-based diets. Journal of Nutritional Biochemistry 2010, 21:255-260.
46. Nagata C., Takatsuka N., Kurisu Y., Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. Journal of Nutrition 1998, 128:209-213.
47. Nestel P.J., Yamashita T., Sasahara T., Pomeroy S., Dart A., Komesaroff P., et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:3392-3398.
48. Nilausen K., Meinertz H. Variable lipemic response to dietary soy protein in healthy, normolipemic men. American Journal of Clinical Nutrition 1998, 68:1380S-1384S.
49. NLEA Nutrition Labeling and Education Act of 1990 1990, Vol. 104. Pub L. No. 101-535, Stat 2353. Washington (DC).
50. Potter S.M., Bakhit R.M., Essex-Sorlie D.L., Weingartner K.E., Chapman K.M., Nelson R.A., et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. American Journal of Clinical Nutrition 1993, 58:501-506.
51. Ramaa C.S., Shirode A.R., Mundada A.S., Kadam V.J. Nutraceuticals - an emerging era in the treatment and prevention of cardiovascular diseases. Current Pharmaceutical Biotechnology 2006, 7:15-23.
52. Reynolds K., Chin A., Lees K.A., Nguyen A., Bujnowski D., He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. American Journal of Cardiology 2006, 98:633-640.
53. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
54. Sacks F.M., Lichtenstein A., van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044.
55. Sacks F.M., Lichtenstein A.H., van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones and cardiovascular health: summary of a statement for professionals from the American Heart Association Nutrition Committee. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:1689-1692.
56. Sagara M., Kanda T., NJelekera M., Teramoto T., Armitage L., Birt N., et al. Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland. Journal of the American College of Nutrition 2004, 23:85-91.
57. Setchell K.D., Cassidy A. Dietary isoflavones: biological effects and relevance to human health. Journal of Nutrition 1999, 129:758S-767S.
58. Shorey R.L., Bazan B., Lo G.S., Steinke F.H. Determinants of hypocholesterolemic response to soy and animal protein-based diets. American Journal of Clinical Nutrition 1981, 34:1769-1778.
59. Song W.O., Chun O.K., Hwang I., Shin H.S., Kim B.-G., Kim K.S., et al. Soy isoflavones as safe functional ingredients. Journal of Medicinal Food 2007, 10:571-580.
60. Steinberg F.M. Soybeans or soymilk: does it make a difference for cardiovascular protection? Does it even matter?. American Journal of Clinical Nutrition 2007, 85:927-928.
61. Steinberg F.M., Guthrie N.L., Villablanca A.C., Kumar K., Murray M.J. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. American Journal of Clinical Nutrition 2003, 78:123-130.
62. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. American Journal of Clinical Nutrition 2007, 85:1148-1156.
63. Teede H.J., Dalais F.S., Kotsopoulos D., Liang Y.L., Davis S., McGrath B.P. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2001, 86:3053-3060.
64. Teixeira S.R., Potter S.M., Weigel R., Hannum S., Erdman J.W., Hasler C.M. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. American Journal of Clinical Nutrition 2000, 71:1077-1084.
65. Thorp A.A., Howe P.R., Mori T.A., Coates A.M., Buckley J.D., Hodgson J., et al. Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers. American Journal of Clinical Nutrition 2008, 88:298-304.
66. Turner R.E., Degnan F.H., Archer D.L. Label claims for foods and supplements: a review of the regulations. Nutrition in Clinical Practice 2005, 20:21-32.
67. van Raaij J.M., Katan M.B., Hautvast J.G., Hermus R.J. Effects of casein versus soy protein diets on serum cholesterol and lipoproteins in young healthy volunteers. American Journal of Clinical Nutrition 1981, 34:1261-1271.
68. van Raaij J.M., Katan M.B., West C.E., Hautvast J.G. Influence of diets containing casein, soy isolate, and soy concentrate on serum cholesterol and lipoproteins in middle-aged volunteers. American Journal of Clinical Nutrition 1982, 35:925-934.
69. Weggemans R.M., Trautwein E.A. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. European Journal of Clinical Nutrition 2003, 57:940-946.
70. Xiao C.W. Health effects of soy protein and isoflavones in humans. Journal of Nutrition 2008, 138:1244S-1249S.
71. Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. American Journal of Clinical Nutrition 2005, 81:397-408.
72. Zhuo X.G., Melby M.K., Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. Journal of Nutrition 2004, 134:2395-2400.